A noninvasive clinicopathologic and gene expression profiling (CP-GEP)–based tool, the Merlin assay, shows promise for identifying recurrence risks in patients with early-stage melanoma who do not ...

"Sun exposure causes damage to the cells in your skin and causes abnormal growth of melanocytes, which is a type of skin cell ...

Skin cancer, including melanoma, is highly treatable when caught in its early stages, Mitchell explained ... such as the scalp, soles of the feet and under the nails. “The examination ...

Several patient-specific factors are associated with an increased rate of advanced melanoma at presentation, including age, gender, and race.

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

Melanoma can spread quickly ... a melanoma at its earliest stage. Even if you don’t notice any warning signs of cancer, it’s important to see your doctor regularly for skin checks to help detect ...

“At early stages, it can often be cured with just a simple excision and has a wonderful prognosis.” But once the cancer spreads, those odds change dramatically. In cases where melanoma hasn ...

The prognosis is "very good" when melanoma is detected early, but the survival rate falls steeply when it is detected at a more advanced stage ... was only on his scalp and hadn’t traveled ...

Patients discontinuing adjuvant immunotherapy early due to ... distant metastatic melanoma. 2 Recurrence brings a high risk of mortality, depending on the cancer’s stage. Anti–programmed ...

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...